'Mk 1602 migraine forecast' presentation slideshows

JSB Market Research: MK-1602 (Migraine)

The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth.

199 views • 7 slides